Inhibition of PI3K and MEK: It Is All about Combinations and Biomarkers

被引：33

作者：

Rexer, Brent N.

Ghosh, Ritwik

Arteaga, Carlos L. ^{[1
]}

机构：

[1] Vanderbilt Univ, Sch Med, Div Oncol, Dept Med, Nashville, TN 37232 USA

来源：

CLINICAL CANCER RESEARCH | 2009年 / 15卷 / 14期

关键词：

CANCER; MTOR; ACTIVATION;

D O I：

10.1158/1078-0432.CCR-09-0872

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

A small molecule inhibitor of MAP/ERK kinase (MEK) was effective against human breast cancer cells with a basal-like gene expression signature. Antitumor activity was limited by both feedback upregulation of phosphatidylinositol-3 kinase (PI3K)/AKT upon inhibition of MEK as well as loss of the phosphatase PTEN. Therefore, MEK inhibitors should preferably be investigated in combination with PI3K inhibitors in basal-like breast cancers. (Clin Cancer Res 2009;15(14) July 2009).

引用

页码：4518 / 4520

页数：3

共 50 条

[21] Combinations of BRAF, MEK, and PI3K/mTOR Inhibitors Overcome Acquired Resistance to the BRAF Inhibitor GSK2118436 Dabrafenib, Mediated by NRAS or MEK Mutations [J].

Greger, James G. ;

Eastman, Stephen D. ;

Zhang, Vivian ;

Bleam, Maureen R. ;

Hughes, Ashley M. ;

Smitheman, Kimberly N. ;

Dickerson, Scott H. ;

Laquerre, Sylvie G. ;

Liu, Li ;

Gilmer, Tona M. .

MOLECULAR CANCER THERAPEUTICS, 2012, 11 (04) :909-920

[22] Inhibition of PI3Kδ Improves Systemic Lupus in Mice [J].

Wang, Yanxia ;

Zhang, Lei ;

Wei, Ping ;

Zhang, Huailiang ;

Liu, Cuijie .

INFLAMMATION, 2014, 37 (03) :978-983

[23] Anti-Myeloma Activity of Akt Inhibition Is Linked to the Activation Status of PI3K/Akt and MEK/ERK Pathway [J].

Ramakrishnan, Vijay ;

Kimlinger, Teresa ;

Haug, Jessica ;

Painuly, Utkarsh ;

Wellik, Linda ;

Halling, Timothy ;

Rajkumar, S. Vincent ;

Kumar, Shaji .

PLOS ONE, 2012, 7 (11)

[24] α-TEA cooperates with MEK or mTOR inhibitors to induce apoptosis via targeting IRS/PI3K pathways [J].

Tiwary, R. ;

Yu, W. ;

Sanders, B. G. ;

Kline, K. .

BRITISH JOURNAL OF CANCER, 2011, 104 (01) :101-109

[25] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer [J].

Huemer F. ;

Bartsch R. ;

Gnant M. .

Current Breast Cancer Reports, 2014, 6 (2) :59-70

[26] Biophysical and Structural Characterization of Novel RAS-Binding Domains (RBDs) of PI3Kα and PI3Kγ [J].

Martinez, Nicholas G. ;

Thieker, David F. ;

Carey, Leiah M. ;

Rasquinha, Juhi A. ;

Kistler, Samantha K. ;

Kuhlman, Brian A. ;

Campbell, Sharon L. .

JOURNAL OF MOLECULAR BIOLOGY, 2021, 433 (08)

[27] The Oncogene Addiction Switch from NOTCH to PI3K Requires Simultaneous Targeting of NOTCH and PI3K Pathway Inhibition in Glioblastoma [J].

Saito, Norihiko ;

Hirai, Nozomi ;

Aoki, Kazuya ;

Suzuki, Ryo ;

Fujita, Satoshi ;

Nakayama, Haruo ;

Hayashi, Morito ;

Ito, Keisuke ;

Sakurai, Takatoshi ;

Iwabuchi, Satoshi .

CANCERS, 2019, 11 (01)

[28] Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib [J].

Till, Kathleen J. ;

Abdullah, Mariah ;

Alnassfan, Tahera ;

Janet, Gallardo Zapata ;

Marks, Thomas ;

Coma, Silvia ;

Weaver, David T. ;

Pachter, Jonathan A. ;

Pettitt, Andrew R. ;

Slupsky, Joseph R. .

SCIENTIFIC REPORTS, 2023, 13 (01)

[29] Pharmacologic Inhibition of SHP2 Blocks Both PI3K and MEK Signaling in Low-epiregulin HNSCC via GAB1 [J].

Kurupi, Richard ;

Floros, Konstantinos, V ;

Jacob, Sheeba ;

Chawla, Ayesha T. ;

Cai, Jinyang ;

Hu, Bin ;

Puchalapalli, Madhavi ;

Coon, Colin M. ;

Khatri, Rishabh ;

Crowther, Giovanna Stein ;

Egan, Regina K. ;

Murchie, Ellen ;

Greninger, Patricia ;

Dalton, Krista M. ;

Ghotra, Maninderjit S. ;

Boikos, Sosipatros A. ;

Koblinski, Jennifer E. ;

Harada, Hisashi ;

Sun, Yue ;

Morgan, Iain M. ;

Basu, Devraj ;

Dozmorov, Mikhail G. ;

Benes, Cyril H. ;

Faber, Anthony C. .

CANCER RESEARCH COMMUNICATIONS, 2022, 2 (09) :1061-1074

[30] A Potential Role for the Inhibition of PI3K Signaling in Glioblastoma Therapy [J].

Stroebele, Stephanie ;

Schneider, Matthias ;

Schneele, Lukas ;

Siegelin, Markus D. ;

Nonnenmacher, Lisa ;

Zhou, Shaoxia ;

Karpel-Massle, Georg ;

Westhoff, Mike-Andrew ;

Halatsch, Marc-Eric ;

Debatin, Klaus-Michael .

PLOS ONE, 2015, 10 (06)

← 1 2 3 4 5 →